Experimental enzyme therapy tested in rare brain disease after transplant
NCT ID NCT01303146
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested an experimental drug called METAZYM (a lab-made enzyme) in one child with late infantile metachromatic leukodystrophy (MLD) who had already received a stem cell transplant. The goal was to see if the enzyme could improve nerve function and reduce harmful buildup in the body. The child received infusions every two weeks for 18 months, with regular checkups on nerve speed, motor skills, and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- METAZYM (recombinant human arylsulfatase A, also called rhASA)
- What this could lead to
- If it works, this could point toward a way to slow nerve damage in children with MLD who have already had a stem cell transplant.
- What could go wrong
- This is a very early, single-patient study, so results may not apply to others. The treatment may not stop the disease from getting worse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATE INFANTILE METACHROMATIC LEUKODYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Pediatric Endocrinology and Neurology, Saint Vincent de Paul Hospital
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Newborn screening study aims to catch rare diseases at birth
- Gene therapy shows promise for rare fatal brain disease in kids
- New stem cell approach aims to tame rare genetic diseases
- New MRI study maps rare brain disease in children
- Brain gene therapy shows promise for rare childhood disease
- Could a single DNA test solve the mystery of rare brain diseases in kids?